Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC)
Publication
, Conference
Li, R; Spiess, PE; Sexton, WJ; Poch, MA; Zemp, L; Pow-Sang, JM; Zhang, J; Dhillon, J; Borjas, G; Naidu, SU; Dorman, D; Burke, JM; Mule, JJ ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Li, R., Spiess, P. E., Sexton, W. J., Poch, M. A., Zemp, L., Pow-Sang, J. M., … Jain, R. K. (2023). Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Li, Roger, Philippe E. Spiess, Wade J. Sexton, Michael Adam Poch, Logan Zemp, Julio M. Pow-Sang, Jingsong Zhang, et al. “Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Li R, Spiess PE, Sexton WJ, Poch MA, Zemp L, Pow-Sang JM, et al. Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC). In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Li, Roger, et al. “Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC).” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.
Li R, Spiess PE, Sexton WJ, Poch MA, Zemp L, Pow-Sang JM, Zhang J, Dhillon J, Borjas G, Naidu SU, Dorman D, Burke JM, Mule JJ, Conejo-Garcia J, Jain RK. Phase Ib neoadjuvant CG0070 and nivolumab (N) for cisplatin (C)-ineligible muscle invasive bladder cancer (MIBC). JOURNAL OF CLINICAL ONCOLOGY. 2023.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences